Molecular genetic mechanisms of allelic specific regulation of murine Comt expression

Pain

Volumn 156, Issue 10, 2015, Pages 1965-1977

  Segall, Samantha K ^a   Shabalina, Svetlana A ^b   Meloto, Carolina B ^c   Wen, Xia ^d   Cunningham, Danielle ^e   Tarantino, Lisa M ^f   Wiltshire, Tim ^a   Gauthier, Josee ^g   Tohyama, Sarasa ^g,h   Martin, Loren J ^g   Mogil, Jeffrey S ^g   Diatchenko, Luda ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNC Hamner Institute for Drug Safety Sciences   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alternative splicing; Comt; Mirna; Molecular genetics; Transcription regulation

Indexed keywords

CATECHOL METHYLTRANSFERASE; MESSENGER RNA; MICRORNA; MICRORNA 3470A; MICRORNA 3470B; MICRORNA 667; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; LENTIVIRINAE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHENOTYPE; POLYADENYLATION; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA DEGRADATION; ANIMAL; BRAIN; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INBRED MOUSE STRAIN; MACROPHAGE; MALE; METABOLISM; PAIN; PAIN MEASUREMENT; PHYSIOLOGY; TRANSFORMED CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BRAIN; CATECHOL O-METHYLTRANSFERASE; CELL LINE, TRANSFORMED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MACROPHAGES; MALE; MICE; MICE, INBRED STRAINS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAIN; PAIN MEASUREMENT; POLYADENYLATION; RNA, MESSENGER; TRANSFECTION;

EID: 84954486353     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000258     Document Type: Article

References (67)

1. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet 2002; 3:370-9.
2. Belfer I, Segall SK, Lariviere WR, Smith SB, Dai F, Slade GD, Rashid NU, Mogil JS, Campbell CM, Edwards RR, Liu Q, Bair E, Maixner W, Diatchenko L. Pain modality-And sex-specific effects of COMT genetic functional variants. PAIN 2013; 154:1368-76.
3. Bevilacqua L, Goldman D. Genetics of emotion. Trends Cogn Sci 2011; 15:401-8.
4. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, ODonovan MC. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003; 73:152-61.
5. Buckert M, Kudielka BM, Reuter M, Fiebach CJ. The COMT Val158Met polymorphism modulates working memory performance under acute stress. Psychoneuroendocrinology 2012; 37:1810-21.
6. Chernova T, Higginson FM, Davies R, Smith AG. B2 SINE retrotransposon causes polymorphic expression of mouse 5-Aminolevulinic acid synthase 1 gene. Biochem Biophys Res Commun 2008; 377:515-20.
7. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, Blelloch R, Schroth GP, Nusbaum C, Bartel DP. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010; 24:992-1009.
8. Deininger PL. SINEs: short interspersed repeat elements in higher eucaryotes. In: Berg DE, Howe MM, editors. Mobile DNA. Washington, DC: American Society of Microbiology, 1989. p. 619-36.
9. Desbonnet L, Tighe O, Karayiorgou M, Gogos JA, Waddington JL, OTuathaigh CM. Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficientmice. Behav Brain Res 2012; 228:351-8.
10. DeYoung CG, Getchell M, Koposov RA, Yrigollen CM, Haeffel GJ, af Klinteberg B, Oreland L, Ruchkin VV, Pakstis AJ, Grigorenko EL. Variation in the catechol-O-methyltransferase Val 158 Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents. Psychiatr Genet 2010; 20:20-4.
11. Diatchenko L, Fillingim RB, Smith SB, Maixner W. The phenotypic and genetic signatures of common musculoskeletal pain conditions. Nat Rev Rheumatol 2013; 9:340-50.
12. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. PAIN 2006; 125:216-24.
13. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS, Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005; 14:135-43.
14. Domschke K, Deckert J, ODonovan MC, Glatt SJ. Meta-Analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 667-73.
15. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 2006; 63:1396-406.
16. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001; 98:6917-22.
17. Evans J, Xu K, Heron J, EnochMA, Araya R, Lewis G, Timpson N, Davies S, Nutt D, Goldman D. Emotional symptoms in children: the effect of maternal depression, life events, and COMT genotype. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:209-18.
18. Guldberg HC, Marsden CA. Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 1975; 27:135-206.
19. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-40.
20. Harrison PJ, Tunbridge EM. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008; 33:3037-45.
21. Hettema JM, An SS, Bukszar J, van den Oord EJ, Neale MC, Kendler KS, Chen X. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry 2008; 64: 302-10.
22. Kambur O, Mannisto PT. Catechol-O-methyltransferase and pain. Int Rev Neurobiol 2010; 95:227-79.
23. Kapitonov VV, Jurka J. A universal classification of eukaryotic transposable elements implemented in Repbase. Nat Rev Genet 2008; 9:411-12; author reply 414.
24. Kember RL, Fernandes C, TunbridgeEM, Liu L, Paya-Cano JL, ParsonsMJ, Schalkwyk LC.A B2 SINE insertion in theComt1 gene (Comt1(B2i)) results in an overexpressing, behavior modifying allele present in classical inbred mouse strains. Genes Brain Behav 2010; 9:925-32.
25. Kondrashov AS, Shabalina SA. Classification of common conserved sequences in mammalian intergenic regions. Hum Mol Genet 2002; 11: 669-74.
26. Kress M, Barra Y, Seidman JG, Khoury G, Jay G. Functional insertion of an Alu type 2 (B2 SINE) repetitive sequence in murine class I genes. Science 1984; 226:974-7.
27. Lachman HM. Does COMT val158met affect behavioral phenotypes: yes, no, maybe? Neuropsychopharmacology 2008; 33:3027-9.
28. Lariviere WR, Wilson SG, Laughlin TM, Kokayeff A, West EE, Adhikari SM, Wan Y, Mogil JS. Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity. PAIN 2002; 97:75-86.
29. Li Z, Mulligan MK, Wang X, Miles MF, Lu L, Williams RW. A transposon in Comt generates mRNA variants and causes widespread expression and behavioral differences among mice. PLoS One 2010; 5:e12181.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8.
31. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34:4202-10.
32. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159:652-4.
33. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999; 51:593-628.
34. Matveeva O, Nechipurenko Y, Rossi L, Moore B, Saetrom P, Ogurtsov AY, Atkins JF, Shabalina SA. Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res 2007; 35:e63.
35. MatveevaOV, Kang Y, SpiridonovAN, SaetromP, Nemtsov VA, OgurtsovAY, Nechipurenko YD, Shabalina SA. Optimization of duplex stability and terminal asymmetry for shRNA design. PLoS One 2010; 5:e10180.
36. MatveevaOV, Nazipova NN, Ogurtsov AY, Shabalina SA. Optimizedmodels for design of efficient miR30-based shRNAs. Front Genet 2012; 3:163.
37. McLean SA, Diatchenko L, Lee YM, Swor RA, Domeier RM, Jones JS, Jones CW, Reed C, Harris RE, Maixner W, Clauw DJ, Liberzon I. Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain 2011; 12:101-7.
38. Michel D, Chatelain G, Mauduit C, Benahmed M, Brun G. Recent evolutionary acquisition of alternative pre-mRNA splicing and 3 processing regulations induced by intronic B2 SINE insertion. Nucleic Acids Res 1997; 25:3228-34.
39. Mier D, Kirsch P, Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-Analysis. Mol Psychiatry 2010; 15:918-27.
40. Mogil JS. Pain genetics: past, present and future. Trends Genet 2012; 28: 258-66.
41. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. Human catechol-Omethyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006; 314:1930-3.
42. Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2-And beta3-Adrenergic receptors. PAIN 2007; 128:199-208.
43. Ogurtsov AY, Shabalina SA, Kondrashov AS, Roytberg MA. Analysis of internal loops within the RNA secondary structure in almost quadratic time. Bioinformatics 2006; 22:1317-24.
44. Palmason H, Moser D, Sigmund J, Vogler C, Hanig S, Schneider A, Seitz C, Marcus A, Meyer J, Freitag CM. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. J Neural Transm 2010; 117:259-67.
45. Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, Weinberger DR, Chen J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 2008; 28:8709-23.
46. Pooley EC, Fineberg N, Harrison PJ. The met(158) allele of catechol-Omethyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-Analysis. Mol Psychiatry 2007; 12:556-61.
47. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet B Neuropsychiatr Genet 2003; 118B:103-9.
48. Roman AC, Benitez DA, Carvajal-Gonzalez JM, Fernandez-Salguero PM. Genome-wide B1 retrotransposon binds the transcription factors dioxin receptor and Slug and regulates gene expression in vivo. Proc Natl Acad Sci U S A 2008; 105:1632-7.
49. Segall SK, Maixner W, Belfer I, Wiltshire T, Seltzer Z, Diatchenko L. Janus molecule I: dichotomous effects of COMT in neuropathic vs nociceptive pain modalities. CNS Neurol Disord Drug Targets 2012; 11:222-35.
50. Segall SK, Nackley AG, Diatchenko L, Lariviere WR, Lu X, Marron JS, Grabowski-Boase L, Walker JR, Slade G, Gauthier J, Bailey JS, Steffy BM, Maynard TM, Tarantino LM, Wiltshire T. Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains ofmice. Genes Brain Behav 2010; 9:933-46.
51. Shabalina SA, Spiridonov AN, Ogurtsov AY. Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics 2006; 7:65.
52. Smit AFA, Hubley R, Green P. RepeatMasker Open-4.0. Available at: http://repeatmasker.org. 2013-2015. Accessed May 2015.
53. Smith SB, MaixnerDW, Greenspan JD, Dubner R, FillingimRB, Ohrbach R, Knott C, Slade GD, Bair E, Gibson DG, Zaykin DV, Weir BS, Maixner W, Diatchenko L. Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. J Pain 2011; 12(11 suppl):T92-101.
54. Stein DJ, Newman TK, Savitz J, Ramesar R. Warriors versus worriers: the role of COMT gene variants. CNS Spectr 2006; 11:745-8.
55. Su AI, Wiltshire T, Batalov S, Lapp H, ChingKA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004; 101:6062-7.
56. Tammimaki A, MannistöPT. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and metaanalysis. Pharmacogenet Genomics 2012; 22:673-91.
57. TanHY, ChenQ, Goldberg TE, Mattay VS, Meyer-LindenbergA, Weinberger DR, Callicott JH. Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory. J Neurosci 2007; 27:13393-401.
58. Thomas M, Lieberman J, Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol 2010; 17:1169-74.
59. Tian B, Hu J, Zhang H, Lutz CS. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 2005; 33: 201-12.
60. Tost H, Alam T, Meyer-Lindenberg A. Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 2010; 34:689-700.
61. Tsao D, Shabalina SA, Gauthier J, Dokholyan NV, Diatchenko L. Disruptive mRNA folding increases translational efficiency of catechol-Omethyltransferase variant. Nucleic Acids Res 2011; 39:6201-12.
62. Tsao D, Wieskopf JS, Rashid N, Sorge RE, Redler RL, Segall SK, Mogil JS, Maixner W, Dokholyan NV, Diatchenko L. Serotonin-induced hypersensitivity via inhibition of catechol O-methyltransferase activity. Mol Pain 2012; 8:25.
63. Wan Y, QuK, ZhangQC, Flynn RA, Manor O, Ouyang Z, Zhang J, Spitale RC, Snyder MP, Segal E, Chang HY. Landscape and variation of RNA secondary structure across the human transcriptome. Nature 2014; 505:706-9.
64. Weinshilboum RM, Raymond FA. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet 1977; 29:125-35.
65. WuC, DelanoDL, MitroN, Su SV, Janes J, McClurg P, BatalovS, WelchGL, Zhang J, Orth AP, Walker JR, Glynne RJ, Cooke MP, Takahashi JS, Shimomura K, Kohsaka A, Bass J, Saez E, Wiltshire T, Su AI. Gene set enrichment in eQTL data identifies novel annotations and pathway regulators. PLoS Genet 2008; 4:e1000070.
66. Xie T, Ho SL, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999; 56:31-8.
67. Young EE, Costigan M, Herbert TA, Lariviere WR. Heritability of nociception IV: neuropathic pain assays are genetically distinct across methods of peripheral nerve injury. PAIN 2014; 155:868-80.